MichaelP.SavageMD

Summary

• Dr. Michael Savage is the Ralph J. Roberts Professor of Cardiology and Director of Interventional Cardiology at Thomas Jefferson University, and Director Emeritus of the Cardiac Catheterization Laboratory at Thomas Jefferson University Hospital in Philadelphia. Dr. Savage was instrumental in the formation of the Jefferson Angioplasty Center, a second-opinion center for high-risk patients with complex cardiovascular disease. Under Dr. Savage’s oversight, the Jefferson team has pioneered many advances in interventional cardiology procedures and was at the forefront of clinical research leading to the development of coronary stents which have revolutionized the treatment of heart disease. Dr. Savage’s research continues to advance the care of patients with cardiac disease by perfecting techniques for less invasive alternatives to heart surgery. He has produced over 300 publications including the textbook, “Clopidogrel and the Newer P2Y12 Antiplatelet Agents”, and serves on the editorial board of several journals. Dr. Savage has received numerous honors for patient care, research and teaching. He is a Fellow of the American College of Cardiology and the American College of Physicians, and has the distinction as a Master Interventionalist of the Society of Cardiac Angiography and Interventions (MSCAI). The journal Public Health recently named him a Top 50 Influencer in Cardiology on Twitter; he can be followed @DocSavageTJU.

Study Summary: Are Latex-containing Swan Ganz Catheters Safe to Use in Patients
Op-Med is a collection of original articles contributed by Doximity members. Right heart catheterization (RHC) using balloon-tip Swan Ganz catheters has a centr